Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell TherapyAasha I. Hoogland, Heather Jim, Sarah L. Eisel et al.|Transplantation and Cellular Therapy|2022Cited by 44
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucelAasha I. Hoogland, Heather Jim, Reena Jayani et al.|Cancer Medicine|2021Cited by 35
Subjective cognition in chimeric antigen receptor T-cell therapy recipients.Anna Barata, Heather Jim, Aasha I. Hoogland et al.|Journal of Clinical Oncology|2020Cited by 1